Search research articles
Contact Us
Filters
Showing results (161-170 of 203) with videos related to
Page
of 21
Sort By:
Kidney International
|
July 15, 2005
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy
Kojiro Nagai, Takeshi Matsubara, Akira Mima, et al.
Internal Medicine (Tokyo, Japan)
|
November 20, 2018
Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions
Sayo Ueda, Taichi Murakami, Hirokazu Ogino, et al.
Plos One
|
January 7, 2017
Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy
Takeyuki Saito, Kazuya Yokota, Kazu Kobayakawa, et al.
Plos One
|
July 26, 2012
Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells
Kazuo Torikoshi, Hideharu Abe, Takeshi Matsubara, et al.
Surgery Today
|
November 3, 2019
Congenital vascular ring
Naoki Yoshimura, Kazuaki Fukahara, Akio Yamashita, et al.
Plos One
|
April 7, 2018
Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study
Fumi Kishi, Kojiro Nagai, Norimichi Takamatsu, et al.
Endocrine Journal
|
June 28, 2017
Ghrelin treatment improves physical decline in sarcopenia model mice through muscular enhancement and mitochondrial activation
Masanori Tamaki, Kazutoshi Miyashita, Aika Hagiwara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 17, 2006
Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy
Takeshi Matsubara, Hideharu Abe, Hidenori Arai, et al.
Endocrinology
|
August 5, 2015
Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice
Masanori Tamaki, Aika Hagiwara, Kazutoshi Miyashita, et al.
Journal of Clinical Biochemistry and Nutrition
|
April 10, 2008
The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions
Kaoru Matsuo, Hidekazu Arai, Kazusa Muto, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 203) with videos related to
Sort By:
Page
of 21
Kidney International
|
July 15, 2005
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy
Kojiro Nagai, Takeshi Matsubara, Akira Mima, et al.
Internal Medicine (Tokyo, Japan)
|
November 20, 2018
Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions
Sayo Ueda, Taichi Murakami, Hirokazu Ogino, et al.
Plos One
|
January 7, 2017
Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy
Takeyuki Saito, Kazuya Yokota, Kazu Kobayakawa, et al.
Plos One
|
July 26, 2012
Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells
Kazuo Torikoshi, Hideharu Abe, Takeshi Matsubara, et al.
Surgery Today
|
November 3, 2019
Congenital vascular ring
Naoki Yoshimura, Kazuaki Fukahara, Akio Yamashita, et al.
Plos One
|
April 7, 2018
Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study
Fumi Kishi, Kojiro Nagai, Norimichi Takamatsu, et al.
Endocrine Journal
|
June 28, 2017
Ghrelin treatment improves physical decline in sarcopenia model mice through muscular enhancement and mitochondrial activation
Masanori Tamaki, Kazutoshi Miyashita, Aika Hagiwara, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 17, 2006
Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy
Takeshi Matsubara, Hideharu Abe, Hidenori Arai, et al.
Endocrinology
|
August 5, 2015
Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice
Masanori Tamaki, Aika Hagiwara, Kazutoshi Miyashita, et al.
Journal of Clinical Biochemistry and Nutrition
|
April 10, 2008
The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions
Kaoru Matsuo, Hidekazu Arai, Kazusa Muto, et al.
Page
of 21